Agenda

  1. Coffee and registration

  2. Welcome and introduction

    Fourat Muziel Fourat Muziel
    Regulatory & Compliance Analyst, Enhesa Product
  3. Session 1: Regulatory landscape & policy updates
  4. PFAS policy, regulatory, and stewardship developments in the U.S.

    • the Administration’s evolving PFAS policy;
    • Federal regulatory initiatives;
    • State regulatory initiatives; and
    • stewardship trends.
    Lynn L. Bergeson Lynn L. Bergeson
    Managing Partner of Bergeson & Campbell, P.C. (B&C®) and President of The Acta Group, L.L.C. (Acta®), Bergeson & Campbell, USA
  5. PFAS regulation in the U.S. States and Canada

    • all PFAS are not the same: overview of sub-groups of PFAS;
    • the unique combination of properties that make fluoropolymers indispensable to multiple industries;
    • an overview of PFAS regulation in the U.S. states with select case studies; and
    • Canada’s approach to PFAS assessment and regulation.
    Jay West Jay West
    Executive Director of ACC’s Performance Fluoropolymer Partnership, American Chemistry Council (ACC)
  6. Using TSCA to turn off the PFAS tap: Opportunities and benefits

    • overview of USEPA approvals to import and produce PFAS;
    • distinguishing among categories of PFAS uses;
    • comparison of what USEPA knows now about the impact of PFAS compared to when many of the approvals to import and produce PFAS were granted; and
    • opportunities for turning off the PFAS tap.
    Maria Doa Maria Doa
    Senior Director, Chemical Policy, Environmental Defence Fund
  7. Q&A session

  8. Refreshment break

  9. Session 2: Global overview
  10. Maine’s PFAS in products program

    • discuss Maine’s law prohibiting PFAS in products sold in the state; and
    • review Maine’s unique currently unavoidable use process, which allows products with this designation to continue to be sold. 
    Kerri Malinowski Farris Kerri Malinowski Farris
    Program Manager for Maine’s Safer Chemicals Program, Maine Department of Environmental Protection
  11. PFAS restrictions in LatAM

    Nidia Mariana Calvo Mendez Nidia Mariana Calvo Mendez
    Americas Managing Analyst, Enhesa Product Intelligence
  12. EU PFAS updates

    • where does the proposed PFAS restriction stand?; and
    • PFAS litigation cases in the EU — something quite new. 
    Herb Estreicher Herb Estreicher
    Partner, Keller and Heckman LLP, United States
  13. Q&A session

  14. Lunch and networking

  15. Welcome back

    Fourat Muziel Fourat Muziel
    Regulatory & Compliance Analyst, Enhesa Product
  16. Session 3: Compliance & industry impact
  17. Toxics Release Inventory (TRI) updates

  18. Major EPA actions to combat PFAS contamination

    • overview of actions announced by USEPA to address PFAS;
    • relationship to USEPA’s powering the Great American Comeback Initiative;
    • guiding principles for USEPA’s actions;
    • comparison to USEPA’s prior PFAS Strategic Roadmap; and
    • progress on USEPA’s actions to date.
    Michael Boucher Michael Boucher
    Partner, Steptoe
  19. PFAS litigation: What it is and why it matters

    Drew Cleary Jordan Drew Cleary Jordan
    Associate, Morgan Lewis
  20. Q&A session

  21. Refreshment break

  22. Session 4: Science, testing & innovation
  23. Evaluating different methods for PFAS analysis of consumer products: How does this impact our assessments?

    • results of a study aimed to quantify PFAS or fluorine content in three distinct consumer products using total fluorine, total inorganic fluoride, solvent extraction, and leachate analyses to assess PFAS presence and bioavailability of PFAS to consumers; and
    • will evaluate the strengths and limitations of each method and assess how data interpretation varies depending on the analytical approach used.
    Elizabeth Denly Elizabeth Denly
    Vice President, PFAS Initiative Leader & Chemistry Director, TRC
  24. Retailer-led solutions to PFAS: Managing chemicals of high concern in the marketplace

    • how regulatory, legal, and reputational risks are prompting retailers to act on PFAS;
    • examples of retailer policies restricting PFAS in products, packaging, and supply chains;
    • business strategies for mitigating PFAS-related risk through transparency and safer chemistry; and
    • how the Retailer Report Card framework, the Essential Elements for a Safer Marketplace, provides a roadmap for businesses to restrict PFAS and advance safer solutions.
    Mike Schade Mike Schade
    Senior Director of Programs and Strategy, Toxic-Free Future, United States
  25. PFAS-Free alternatives & sustainable innovation  / avoiding regrettable substitution

    Baskut Tuncak Baskut Tuncak
    Director, Toxics Use Reduction Institute, TURI
  26. Q&A session

  27. Close of conference